Eric Richman - May 19, 2022 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Signature
/s/ /s/ Eric I Richman
Stock symbol
GANX
Transactions as of
May 19, 2022
Transactions value $
$37,034
Form type
4
Date filed
5/23/2022, 04:41 PM
Previous filing
Mar 7, 2022
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common stock Purchase $10.8K +4K +1.98% $2.71 206K May 19, 2022 Direct
transaction GANX Common Stock Purchase $26.2K +9.26K +4.49% $2.83 215K May 20, 2022 Direct F1
holding GANX Common Stock 14.8K May 19, 2022 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.97 inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownershipof the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.